Kobayashi Pharmaceutical Co Ltd
TSE:4967
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4 875
6 927
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Kobayashi Pharmaceutical Co Ltd
Net Margin
Kobayashi Pharmaceutical Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | JP |
| Market Cap | 448.7B JPY |
| Net Margin |
8%
|
| Country | FR |
| Market Cap | 177.2B EUR |
| Net Margin |
15%
|
| Country | UK |
| Market Cap | 118.1B GBP |
| Net Margin |
11%
|
| Country | IN |
| Market Cap | 5.8T INR |
| Net Margin |
17%
|
| Country | UK |
| Market Cap | 34.2B GBP |
| Net Margin |
11%
|
| Country | DE |
| Market Cap | 27.7B EUR |
| Net Margin |
8%
|
| Country | US |
| Market Cap | 26.3B USD |
| Net Margin |
1%
|
| Country | JP |
| Market Cap | 3T JPY |
| Net Margin |
5%
|
| Country | IN |
| Market Cap | 1.3T INR |
| Net Margin |
-3%
|
| Country | IN |
| Market Cap | 932.4B INR |
| Net Margin |
14%
|
| Country | US |
| Market Cap | 10.1B USD |
| Net Margin |
12%
|
Kobayashi Pharmaceutical Co Ltd
Glance View
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,451 full-time employees. The firm operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Kobayashi Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 8%.
You don't have any saved screeners yet
